热门资讯> 正文
Teanx Therapeutics计划进行二次发行
2025-04-16 14:57
- Tenax Therapeutics (NASDAQ:TENX) filed a prospectus for resale by the selling stockholder of up to 378,346 shares of common stock and up to ~3.76M shares of common stock issuable upon the exercise of pre-funded warrants.
- The company will not receive any proceeds from the sale.
- Source: Form S-3 filing
More on Tenax Therapeutics
- Tenax Therapeutics announces $25M private placement
- Seeking Alpha’s Quant Rating on Tenax Therapeutics
- Historical earnings data for Tenax Therapeutics
- Financial information for Tenax Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
